Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesEBIATMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges (2019 - 2025)

Fennec Pharmaceuticals' Amortization - Deferred Charges history spans 7 years, with the latest figure at $26000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Deferred Charges rose 4.0% year-over-year to $26000.0, compared with a TTM value of $64000.0 through Dec 2025, down 28.09%, and an annual FY2025 reading of $64000.0, down 28.09% over the prior year.
  • Amortization - Deferred Charges for Q4 2025 was $26000.0 at Fennec Pharmaceuticals, up from $12000.0 in the prior quarter.
  • The five-year high for Amortization - Deferred Charges was $73000.0 in Q2 2023, with the low at $7000.0 in Q1 2022.
  • Average Amortization - Deferred Charges over 5 years is $35117.6, with a median of $23000.0 recorded in 2024.
  • Year-over-year, Amortization - Deferred Charges plummeted 97.75% in 2021 and then surged 928.57% in 2023.
  • Tracing FENC's Amortization - Deferred Charges over 5 years: stood at $8000.0 in 2021, then soared by 775.0% to $70000.0 in 2022, then changed by 0.0% to $70000.0 in 2023, then crashed by 64.29% to $25000.0 in 2024, then grew by 4.0% to $26000.0 in 2025.
  • Per Business Quant, the three most recent readings for FENC's Amortization - Deferred Charges are $26000.0 (Q4 2025), $12000.0 (Q3 2025), and $13000.0 (Q2 2025).